COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is providing an update and summary of our goals and product line advancements. Some products are currently available to patients with legal state medical marijuana access, and others are up and coming over-the-counter products that will be available to the public nationally and internationally.
